Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric eluxadoline dose-ranging study in irritable bowel syndrome with diarrhea
NL-OMON49257Phase 2Active, not recruiting
- Sponsor
- Allergan
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of eluxadoline, sponsored by Allergan. Started Sep 2020; status: active, not recruiting.
02
Drugs
eluxadoline
Beyond the preview
Go deeper on NL-OMON49257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49257.